MEDPAL AI is trading 10.26% up now at £6.34 after a technical rebound from the placing-related selloff.

  • The company announced a £5 million placing of 100 million shares at 5.0 pence, a 17% discount to the September 18 closing price, raising dilution concerns.
  • The fundraising supports medication-stock working capital and automation expanding GLP-1 capacity to 14,000 daily orders.
  • September annualised revenue exceeded £35 million, providing a positive growth counterpoint.